@misc{indiciaeca6bff2fed3a,
  title = {Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.},
  author = {F A Holmes and J A O'Shaughnessy and S Vukelja and S E Jones and J Shogan and M Savin and J Glaspy and M Moore and L Meza and I Wiznitzer and T A Neumann and L R Hill and B C Liang},
  year = {2002},
  doi = {10.1200/jco.2002.20.3.727},
  url = {https://pubmed.ncbi.nlm.nih.gov/11821454/},
  note = {Source identifier: 11821454}
}